Literature DB >> 4045027

Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function.

J M Arnold, E Braunwald, T Sandor, R A Kloner.   

Abstract

Prolonged postischemic ventricular dysfunction ("stunned myocardium") may be responsible for heart failure after myocardial reperfusion. Although inotropic stimulation can enhance the contractility of stunned myocardium, it could potentially increase infarct size and thereby impair ultimate recovery of myocardial function. In 16 anesthetized dogs, the left anterior descending coronary artery was occluded for 2 hours, and then reperfused. At 45 minutes of reperfusion, the dogs were randomized to receive a 3 hour intravenous infusion of either saline solution or dopamine (10 micrograms/kg per min), and 1 hour after the infusion was discontinued the area of necrosis and an in vivo area at risk of necrosis were determined. All dogs had serial two-dimensional echocardiograms with computer-assisted analysis and in vivo biopsies for determination of adenosine triphosphate and creatine phosphate levels. Dopamine caused an increase in the contractility of the reperfused myocardium, with systolic wall thickening increasing from -4.1 +/- 2.6 (mean +/- SEM) to +24.0 +/- 3.7% (p less than 0.002) and short-axis cross-sectional ejection fraction increasing from 27.1 +/- 4.7 to 71.6 +/- 4.4% (p less than 0.002) after 15 minutes of infusion. Regional myocardial blood flow in the previously ischemic epicardium was increased from 1.18 +/- 0.11 ml/min per g with saline to 2.95 +/- 0.36 ml/min per g with dopamine (p less than 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045027     DOI: 10.1016/s0735-1097(85)80305-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Epinephrine-stimulated contractile and metabolic reserve in postischemic rat myocardium.

Authors:  G Görge; I Papageorgiou; R Lerch
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

Review 2.  Stunning of the myocardium: an update.

Authors:  E Braunwald
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 3.  The Oxygen Paradox, the French Paradox, and age-related diseases.

Authors:  Joanna M S Davies; Josiane Cillard; Bertrand Friguet; Enrique Cadenas; Jean Cadet; Rachael Cayce; Andrew Fishmann; David Liao; Anne-Laure Bulteau; Frédéric Derbré; Amélie Rébillard; Steven Burstein; Etienne Hirsch; Robert A Kloner; Michael Jakowec; Giselle Petzinger; Delphine Sauce; Florian Sennlaub; Isabelle Limon; Fulvio Ursini; Matilde Maiorino; Christina Economides; Christian J Pike; Pinchas Cohen; Anne Negre Salvayre; Matthew R Halliday; Adam J Lundquist; Nicolaus A Jakowec; Fatima Mechta-Grigoriou; Mathias Mericskay; Jean Mariani; Zhenlin Li; David Huang; Ellsworth Grant; Henry J Forman; Caleb E Finch; Patrick Y Sun; Laura C D Pomatto; Onnik Agbulut; David Warburton; Christian Neri; Mustapha Rouis; Pierre Cillard; Jacqueline Capeau; Jean Rosenbaum; Kelvin J A Davies
Journal:  Geroscience       Date:  2017-12-21       Impact factor: 7.713

4.  Xamoterol recruits an inotropic reserve in the acutely failing, reperfused canine myocardium without detrimental effects on its subsequent recovery.

Authors:  S Schäfer; C Linder; G Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

5.  Effect of pyruvate on regional ventricular function in normal and stunned myocardium.

Authors:  R M Mentzer; D G Van Wylen; J Sodhi; R J Weiss; R D Lasley; J Willis; R Bünger; L M Flint
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

Review 6.  Stunning: damaging or protective to the myocardium?

Authors:  R Ferrari; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 7.  Calcium antagonists and stunned myocardium: importance for clinicians?

Authors:  K Przyklenk; R A Kloner
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 8.  Clinical relevance of myocardial "stunning".

Authors:  R Bolli; C J Hartley; R S Rabinovitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 9.  Role of adenosine in the treatment of myocardial stunning.

Authors:  M B Forman; C E Velasco
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 10.  Features of short-term myocardial hibernation.

Authors:  G Heusch; R Schulz
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.